1. Home
  2. ENS vs ABVX Comparison

ENS vs ABVX Comparison

Compare ENS & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EnerSys

ENS

EnerSys

HOLD

Current Price

$222.03

Market Cap

8.2B

Sector

Technology

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$119.44

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENS
ABVX
Founded
1991
2013
Country
United States
France
Employees
9200
67
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
ENS
ABVX
Price
$222.03
$119.44
Analyst Decision
Strong Buy
Buy
Analyst Count
3
13
Target Price
$193.00
$131.31
AVG Volume (30 Days)
268.5K
768.7K
Earning Date
05-20-2026
03-23-2026
Dividend Yield
0.51%
N/A
EPS Growth
38.31
N/A
EPS
5.65
N/A
Revenue
$216,125,000.00
N/A
Revenue This Year
$4.49
$52.14
Revenue Next Year
$3.41
$4,132.27
P/E Ratio
$38.34
N/A
Revenue Growth
15.85
N/A
52 Week Low
$76.60
$5.59
52 Week High
$239.69
$148.83

Technical Indicators

Market Signals
Indicator
ENS
ABVX
Relative Strength Index (RSI) 56.21 52.33
Support Level $152.19 $107.29
Resistance Level N/A $129.73
Average True Range (ATR) 7.38 4.75
MACD -1.79 -0.46
Stochastic Oscillator 44.39 51.69

Price Performance

Historical Comparison
ENS
ABVX

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: